- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Unethical to give COVID booster doses now: Serum Institute CEO
Bengaluru: Serum Institute of India CEO Adar Poonawalla on Friday said that it was unethical to start giving the third booster dose of Covid vaccine to someone when others in certain countries and populations have not even got two doses for full vaccination.
"For example, only 2 to 3 per cent of developing world countries have received vaccines, while it has gone up to 40 to 50 per cent in the developed world.
"The third dose of vaccine is not right, at least till significant part of the other countries get 2 doses and then, of course, we look into third dose or an annual booster shot or something like that," he said at a media interaction along with Biocon chief Kiran Majumdar Shaw after announcing the strategic partnership forged between the Biocon Biologics Ltd (BBL) and the Serum Institute Life Sciences (SILS).
Read also: Biocon Biologics, Serum Institute Life Sciences enter strategic alliance
Poonawala said that the "jury is still out there on the third dose".
"Maybe some very vulnerable sections, immuno-compromised people could do with some booster shots. There is no evidence to show Covishield requires a third dose. Some people may have taken it... we have not recommended it yet," he said.
The government and drug controller's office will have to take a decision on the third booster dose based on data and cases as times goes on and including how effective the vaccine is on the Delta virus variant, he added.
"I know some vaccines in the West recommending the third dose because the antibody response has dropped a little, but we will wait and see, the goal is to give two doses to everyone and then look at three doses as a booster," he said.
"We are fortunate in India being in the developing world, having many Indian manufacturers... they have been able to give the population vaccines. But, if we didn't have them in India, we would be in the same position as African countries who have not been able to get vaccines," Poonawalla added.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.